Mutations in the tumour suppressor genes SMAD4 (DPC4, deleted in pancreatic cancer locus 4) and adenomatous polyposis coli (APC) have been implicated in the development of pancreatic cancer in humans. mice exhibit a significant increase in abnormal pancreas, which was found to be due to increased number of abnormal foci rather than increased focus size. A range of foci sizes were analysed, but only smaller abnormal foci were characterized by morphological nuclear atypia. These studies suggest functional co-operation between TGF-b and Wnt signalling pathways in the suppression of pancreatic tumorigenesis in the mouse.
Mutations in the tumour suppressor genes SMAD4 (DPC4, deleted in pancreatic cancer locus 4) and adenomatous polyposis coli (APC) have been implicated in the development of pancreatic cancer in humans. Treatment of wild-type, Smad4 +/7 , Apc Min/+ or Apc Min/+ Smad4 +/7 mice with N-Nitroso-N-Methyl Urea (NMU) results in abnormal foci in pancreatic acinar cells characterized by increased levels of bcatenin. Previously such foci have been shown to be the precursors of pancreatic neoplasia. Interestingly, only NMU-treated Apc Min/+ Smad4
mice exhibit a significant increase in abnormal pancreas, which was found to be due to increased number of abnormal foci rather than increased focus size. A range of foci sizes were analysed, but only smaller abnormal foci were characterized by morphological nuclear atypia. These studies suggest functional co-operation between TGF-b and Wnt signalling pathways in the suppression of pancreatic tumorigenesis in the mouse. Oncogene (2002 Oncogene ( ) 21, 4696 -4701. doi:10.1038 Keywords: pancreas; SMAD4; APC; mouse Genes identified as mutated in pancreatic cancer include p53, p16, K-RAS, BRCA2, APC and p15 (Abraham et al., 2002; Conlon and Howe, 1997; Hahn and Schmiegel, 1998; Caldas et al., 1994; Rozenblum et al., 1997) . SMAD4, also known as DPC4, has also been implicated in pancreatic neoplasia (Hahn et al., 1996a,b) . SMAD4, situated on the long arm of human chromosome 18 (its mouse homologue, designated Smad4, is on chromosome 8), is part of a family of SMAD genes which together work to transduce TGF-b superfamily signalling (Heldin et al., 1997) . Several pieces of evidence support the assignment of Smad4 as a tumour suppressor gene (TSG) in the pancreas. First, loss of heterozygosity (LOH) at 18q has been reported in 90% of pancreatic carcinomas (Hahn et al, 1996a) . Second, 50% of human pancreatic carcinomas are characterized by either homozygous deletion or biallelic mutation of SMAD4 (Hahn et al, 1996a,b; Schutte et al., 1996) . Third, SMAD4 has been linked to tumour suppression-related activities in vitro: Atfi et al. (1997) have shown SMAD4-dependent induction of apoptosis via integration of TGF-b and SAPK -JNK pathways and others have shown that functional SMAD4 is necessary for TGF-b-mediated induction of p21 resulting in growth inhibition (Grau et al., 1997) . Fourth, and perhaps most importantly, SMAD4 has been shown to be the central mediator of TGF-b superfamily signalling, a pathway frequently dysregulated in many cancers including pancreatic cancers (Markowitz and Roberts, 1996; de Caestecker et al., 2000) .
Adenomatous polyposis coli (APC) has been documented as an important TSG in the colon, where germline mutations in APC cause Familial Adenomatous Polyposis (FAP) (Polakis, 1997; Groden et al., 1991) . An ethylnitrosourea-induced germ line mutation within the Apc gene produced a mouse model for FAP, the 'Min' mouse (Apc Min/+ ) (Moser et al., 1990) . As well as intestinal neoplasia, the Apc Min/+ mouse is predisposed to the development of abnormal acinar foci characterized by high levels of b-catenin. In the absence of p53, these b-catenin-overexpressing abnormal foci progress to adenoma and adenocarcinoma (Clarke et al., 1995; Kongkanuntn et al., 1999) . APC, a component of the Wnt signalling pathway, is thought to mediate its tumour suppressive activities predominantly through down-regulation of intracellular bcatenin levels (Munemitsu et al., 1995) . Loss of functional APC results in increased levels of b-catenin, which upon nuclear translocation mediates transcription of target genes, including cyclin D1 and c-myc (He et al., 1998; Tetsu and McCormick, 1999) .
Whilst SMAD4 has been linked to tumour suppression-related activities in vitro, the relevance to pancreatic neoplasia in vivo remains unclear. Smad4 null embryos die around day E7.5, whereas heterozygous mice survive and develop intestinal polyps by 12 months (Sirard et al., 1998; Yang et al., 1998; Xu et al., 2000; Takaku et al., 1999) . Although Smad4 LOH was reported in later stage intestinal tumours (Miyaki et al., 1999) , Xu et al. (2000) found that heterozygosity in this model was sufficient to initiate tumorigenesis in the intestine. Mice heterozygous for inactivating mutations in both Smad4 and Apc (Apc D716 ) developed colorectal carcinomas that were larger in size and more invasive by 20 weeks of age than those found in Apc D716 heterozygotes alone (Takaku et al., 1998) . This suggests that SMAD4 plays a significant role in the malignant progression of colorectal tumours, but the precise biological role of SMAD4 in the progression of pancreatic tumorigenesis in vivo remains unclear. Although SMAD4 mutation is linked with 50% of pancreatic tumours in human, to date no pancreatic phenotype has been reported for any murine transgenic Smad4 strain.
To address the role of SMAD4 in the development of pancreatic cancer, we therefore compared the susceptibility of wild-type mice and mice heterozygous for either or both the Apc Min and Smad4 alleles to the carcinogen NMU. NMU is an alkylating agent and a potent mutagen, exposure to which has been shown to result in pancreatic acinar cell hyperplasia in rats and the development of lymphoma and mammary tumours in mice (Monis et al., 1991; Diamond et al., 1987; Barka, 1982) . We therefore utilized NMU to address the need for additional mutation, that could include mutation in the remaining Smad4 or Apc wild-type alleles. Given the established synergy between mutant Apc Min and Smad4 alleles in colorectal cancer (Takaku et al., 1998) , we also investigated whether mutations in these genes co-operate in pancreatic tumorigenesis.
NMU was administered subcutaneously to littermate cohorts (6 -10 animals) of 4-day-old mice of genotype (i) wild-type, (ii) Smad4 +/7 , (iii) Apc Min/+ or (iv) Apc Min/+ Smad4 +/7 . At 65 days of age the animals were sacrificed and tissues harvested. Age-matched control animals from each genotype were also examined. Given that pancreatic lesions that arise spontaneously in Apc Min/+ mice and are characterized by high b-catenin levls have been shown to be precursors of pancreatic cancer (Clarke et al., 1995; Kongkanuntn et al., 1999) , we performed immunohistochemistry for b-catenin on pancreas from mice of each genotype treated with NMU and control mice. The pancreata of control mice were histologically normal. NMU-treated mice of all genotypes (including WT) exhibited multiple focal acinar cell hyperplasia which was characterized by increased levels of bcatenin ( Figure 1a) .
Two histologically identifiable types of abnormal foci were found, which we postulate reflect different stages or endpoints of the carcinogenic challenge. The majority were composed entirely of acinar cells, while a minority contained stromal cells and cystic areas (Figure 1a,b) . The proportion of the two types of foci did not differ between genotypes. TUNEL staining (Gavrieli et al., 1992) and morphological analysis (Kerr et al., 1972) of these foci revealed higher levels of apoptosis within foci characterized by stroma and cystic areas (2.4% TUNEL positive cells and 1.0% as scored morphologically) than the wholly acinar foci (50.1% TUNEL positive cells, and 0.2% as scored Using increased levels of b-catenin as a marker for abnormal pancreatic foci, the area of pancreas occupied by abnormal foci and focus size were measured by morphometric analysis. Comparison of abnormal pancreas expressed as a percentage of total pancreas found no differences between Smad4 +/7 , Apc Min/+ or WT mice (Mann -Whitney U, P40.05), whereas Apc Min/+ Smad4 +/7 mice showed a significant increase in abnormal pancreas (Figure 2a , MannWhitney U P50.05). Increased abnormal pancreas only when Apc and Smad4 mutation are present in conjunction suggests that the pathways these proteins are involved in converge on a common target. This hypothesis is supported by previous work by Nishita et al. (2000) and Labbe et al. (2000) where interaction of members of the Smad family with LEF1/TCF (Lymphoid enhancing binding factor/T cell-specific factor) and b-catenin was reported.
The observed increase in abnormal pancreas in Smad4 +/7 Apc Min/+ mice argues that SMAD4 is acting as a tumour suppressor in normal pancreas. To investigate whether lesions arising in Apc Min/+ Smad4 +/7 pancreas had lost SMAD4 expression, immunohistochemical analysis for SMAD4 was carried out. The majority of foci remained heterozygous for Smad4 (Figure 1c ) with strong cytoplasmic staining. Decreased cytoplasmic levels of SMAD4 expression were observed only within a minority of foci ( Figure  1d ,e) indicating that loss or down-regulation of the remaining wild-type Smad4 allele occurs rarely in this model. Thus it appears that the increase in abnormal pancreas in the Apc Min/+ Smad4 +/7 mice is associated almost entirely with Smad4 heterozygosity. This suggests that in the presence of other mutations loss of a single Smad4 allele could effect a progression in tumorigenesis.
Statistical analysis comparing focus size between genotypes revealed that abnormal foci arising in Apc Min/+ Smad4 +/7 mice were not significantly larger than those in Smad4 +/7 , Apc Min/+ or wild-type mice (Mann -Whitney U P40.05), Figure 2b . This implies that the increased amount of abnormal pancreas seen in Apc Min/+ Smad4 +/7 mice is not due to increased focus size but rather increased incidence. Mutations in both these genes therefore appear to have an additive effect on the initiation but not growth of abnormal foci causing a resultant overall increase in percentage abnormal pancreas. Takaku et al. (1998) mice and found a decrease in polyp number, but an increase in polyp size and frequency of invasive adenocarcinomas when compared to Apc D716 heterozygotes. Our work is therefore in contrast to that of Takaku et al and may be indicative of different pathways of tumorigenesis in the pancreas and intestine, affecting different target genes. An example of such tissue-specific differences include Smad4-independent inactivation of TGF-b signalling (through inactivation of Smad2 or TGF-b type II receptors), which occurs more often in colorectal tumorigenesis (Heldin et al., 1997) . Finally, the absence of pancreatic neoplasia in the Apc D716/+ Smad4 +/7 mice could be because mutation in genes other than Apc or Smad4 is necessary to initiate pancreatic tumorigenesis. Such Min/+ Smad4 +/7 (219) mice (bracketed values denote total numbers of foci included in dataset). Box plots express the first (Q1) and third (Q3) quartiles within a given data set by the upper and lower horizontal lines in a rectangular box, inside which is a horizontal line showing the median. The whiskers extend upward and downwards to the highest or lowest observation within the upper (Q3+1.5 X the interquartile range) and lower (Q171.5 X interquartile range) limits. Values outside the upper and lower limits are 'outliers' and are shown by individual symbols genes could be targeted by NMU in our study. In humans, oncogenic K-RAS activation and p53 inactivation occur frequently in pancreatic tumorigenesis (Rozenblum et al., 1997; Scarpa et al., 1993; Almoguera et al., 1988) . Notably N-nitroso carcinogens have been shown to induce activating mutations in K-ras in mice (Corominas et al., 1991) , but they have not been shown to cause mutational inactivation of p53 (Kito et al., 1996) .
Histological analysis revealed that a subset of abnormal foci in all genotypes contained visibly larger nuclei ( Figure 1f ) consistent with dysplasia. To examine whether SMAD4 played a role in the dysplastic phenotype, we measured nuclear area (NA) in normal acinar cells and acinar cells within abnormal foci (denoted Class I, Class II and Class III according to increasing size, see Figure 3 legend) for each genotype (Figure 3) . In wild-type, Smad4 +/7 and Apc Min/+ mice, the distribution of NA in all classes of abnormal foci differed significantly from that of normal nuclei (P50.05, Kolmogorov Smirnov or KS), but the greatest increases in NA compared to normal nuclei were observed in the smaller foci, Class I and II, while the distribution of NA in the larger abnormal foci (Class III) more closely resembled that of normal nuclei. Abnormal foci arising in Apc Min/+ Smad4
pancreas differed in that changes in NA distribution were much less pronounced and only Class I abnormal foci exhibited a significant change in NA distribution (KS, P50.05).
Increased NA has been shown to denote a change in DNA content consistent with genomic instability (Asamura et al., 1989; Suzuki et al., 2000) . To investigate whether the nuclear atypia reported above was associated with increased DNA content, we administered NMU using the same method to WT animals hemizygous for the b-globin transgene Tg(Hbb-b1)83Clo present on chromosome 3 and detectable by DNA -DNA in situ hybridization (Keighren and West, 1993) . This method, previously used to identify abnormal ploidy (Keighren and West, 1993) , provides a visual cue to the ploidy status of a cell. This study utilised a double labelling technique involving DNA -DNA in situ labelling of the b-globin transgene and b-catenin immunohistochemistry. Increases in the number of b-globin hybridization spots were seen only in abnormal foci (Figure 1g ), suggesting that in this system increased NA is associated with increased DNA content. An increase in the number of b-globin hybridization spots could reflect an increased proportion of cells blocked in the G2 phase of the cell cycle due to increased cell turnover, but this is unlikely since b-globin staining was not present in doublets characteristic of G2 phase (Lawrence et al., 1990) . Furthermore, BrdU incorporation studies (Figures 1h and 4 ) revealed low levels of Approximately 500 nuclei were scored per class from a minimum of 10 lesions, from at least four mice. Since foci larger than 0.1 mm 2 in each genotype numbered less than 10, they were excluded from the dataset as statistical analysis would be invalid. Results of Kolmogorov Smirnov two-sample test (Sokal and Rohlf, 1995) are shown in tables above respective genotype. N denotes NA in normal tissue; I, NA in Class I abnormal foci; II, Class II; III, Class III. Key for tables: NS, P40.05 and *P50.05 cell turnover, insufficient to account for increased NA seen in approximately 40% of cells within abnormal foci. Thus the increase in nuclear area in the abnormal foci is most likely due to polyploidy or aneuploidy affecting chromosome 3.
Since the greatest increases in NA were not associated with either the largest lesions (Class III) or the most predisposing genotype (Apc Min/+ , Smad4 +/7 ), these results suggest that the processes leading to nuclear atypia and increased focus size may be independent. Although unlikely, it is possible that genomic instability is required in the less predisposing genotypes for lesion initiation but is incompatible with continued progression.
In conclusion, our results provide in vivo evidence from murine models that heterozygous mutation at the Smad4 locus can predispose toward pancreatic tumorigenesis. Furthermore, since this effect only occurs in conjunction with an Apc mutation this suggests that functional co-operation between TGF-b and Wnt signalling pathways may be involved. Histogram showing percentage cells incorporating BrdU in normal (from control and treated mice) and abnormal pancreas tissue. BrdU (Amersham, 3 mg/100 g body weight) was delivered 24 h prior to culling. After processing, immunohistochemistry for b-catenin and BrdU was carried out to enable scoring in both abnormal and normal pancreas. Error bars express standard error of the mean and in each case sections from a minimum of three mice were scored
